Positive outcome for Aerocrine in patent proceedings against Medisoft in Belgium

SOLNA, Sweden - 29 June, 2012

Aerocrine AB (OMX Nordic Exchange: AERO) today announced the positive outcome of its complaint against Medisoft S.A. filed at the Liège Commercial Court, Belgium.
On 14 October 2011, Aerocrine started infringement proceedings against the Belgian company Medisoft S.A. before the Liège Commercial Court, on the basis of four of Aerocrine´s patents. Medisoft challenged both infringement and the validity of the patents as part of its defense. The oral hearings on the merits took place during the spring 2012.

Yesterday the Court upheld Aerocrine’s patents EP 1,439,781 and EP 1,661,514 as valid and ruled that both the Medisoft Hyp’Air FeNO and Hyp’Air FeNO+ devices infringe these patents. Accordingly, Medisoft which is headquartered in Belgium, will be immediately prohibited as from service of the decision, from manufacturing, using, maintaining, detaining and offering for sale any Hyp’Air products.

The Court also invalidated Aerocrine´s earliest patents EP 0,606,351 and EP 0,724,723 for Belgium. These patents expire in 2012 and 2014.
The judgment may be appealed by both parties.
Based on a press release

What do you think about this article and us? Please leave a comment!